Literature DB >> 12658815

The endoscopic retrograde cholangiopancreatographic manifestations of histopathologically diagnosed hepatocellular carcinoma with obstructive jaundice.

Qiu Zhao1, Biao Gong, Naixi Lu, Nanzhi Liu.   

Abstract

To study the manifestations of endoscopic retrograde cholangiopancreatography (ERCP) in patients of obstructive jaundice associated with HCC, 32 cases of histopathologically diagnosed HCC with obstructive jaundice were successfully examined with routine ERCP. 31 patients were demonstrated by ERCP as having malignant obstructive jaundice. Among them, 19 were hepatic perihilar bile duct stricture, 7 bile ductile tumorous thrombus, 3 perihilar bile duct stricture complicated with thrombus, 2 metastasis to hilar lymph node, and 1 common bile duct stone as proven by sphincterotomy. The malignant perihilar stricture was all of type III and IV by Bismuth standard of Klastin tumor. In patients identified as having bile duct tumor thrombus, by the Ueda classification, none was of type I and II; 1 type III a; 4 III b; 2 type IV. HCC with obstructive jaundice was mainly caused by the malignant infiltration of tumor, and most stricture was of serious nature. When major extra-hepatic bile duct was involved by tumor thrombus, obstructive jaundice might develop. Malignant perihilar stricture and tumor thrombus might coexist in some patients. Jaundice was rarely caused by hepatic hilar lymph node metastasis. Jaundice was not necessarily caused by tumors and sometimes, it might be caused by common bile stones. Care should be exercised in differentiation diagnosis in such patients.

Entities:  

Mesh:

Year:  2002        PMID: 12658815     DOI: 10.1007/BF02828191

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Intraluminal bile duct hepatocellular carcinoma.

Authors:  J M Kirk; D Skipper; A E Joseph; G Knee; A Grundy
Journal:  Clin Radiol       Date:  1994-12       Impact factor: 2.350

2.  Surgery for biliary obstruction by tumour thrombus in primary liver cancer.

Authors:  B Tantawi; D Cherqui; J Tran van Nhieu; M Kracht; P L Fagniez
Journal:  Br J Surg       Date:  1996-11       Impact factor: 6.939

3.  Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi.

Authors:  M Ueda; T Takeuchi; T Takayasu; K Takahashi; S Okamoto; A Tanaka; T Morimoto; K Mori; Y Yamaoka
Journal:  Hepatogastroenterology       Date:  1994-08

4.  Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion.

Authors:  A A Polydorou; S R Cairns; J F Dowsett; A R Hatfield; P R Salmon; P B Cotton; R C Russell
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

5.  Management of hepatocellular carcinoma presenting as obstructive jaundice.

Authors:  W Y Lau; J W Leung; A K Li
Journal:  Am J Surg       Date:  1990-09       Impact factor: 2.565

6.  Biliary tract invasion and obstruction by hepatocellular carcinoma: report of five cases.

Authors:  S T Lai; K T Lam; K C Lee
Journal:  Postgrad Med J       Date:  1992-12       Impact factor: 2.401

7.  Hepatocellular carcinoma presenting as intrabile duct tumor growth: a clinicopathologic study of 24 cases.

Authors:  M Kojiro; K Kawabata; Y Kawano; F Shirai; N Takemoto; T Nakashima
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

8.  Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases.

Authors:  M F Chen; Y Y Jan; L B Jeng; T L Hwang; C S Wang; S C Chen
Journal:  Cancer       Date:  1994-03-01       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.